Concepedia
Statistics
Publications
10
Citations
371
H-Index
Active since
1985
Affiliations
Wilmington University(Current)
Bayer (United States)
Donald J. Wolanin is an author at Wilmington University specializing in pharmacology, medicine, and biochemistry.
Top concepts
MedicinePharmacologyBiochemistryDrug DiscoveryChemistryPharmacotherapyDrug DevelopmentNatural SciencesOrganic ChemistryMolecular Pharmacology
Publications per year
1985–2003
Orally Active Trifluoromethyl Ketone Inhibitors of Human Leukocyte Elastase
Chris A. Veale, Peter R Bernstein, Claudia Bohnert et al. · Journal of Medicinal Chemistry · 1997 · 70 citations · Full text
Medicinal Chemistry, Oral Bioavailability, Pharmaceutical Science +13
Peptidyl .alpha.-ketoheterocyclic inhibitors of human neutrophil elastase. 2. Effect of varying the heterocyclic ring on in vitro potency
Philip D. Edwards, Donald J. Wolanin, Donald W. Andisik et al. · Journal of Medicinal Chemistry · 1995 · 69 citations · Full text
Discovery and Biological Activity of Orally Active Peptidyl Trifluoromethyl Ketone Inhibitors of Human Neutrophil Elastase
Philip D. Edwards, Donald W. Andisik, Craig A. Bryant et al. · Journal of Medicinal Chemistry · 1997 · 51 citations · Full text
Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors
Uday R. Khire, Donald Bankston, J A Barbosa et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 44 citations · Full text
Molecular Pharmacology, Biochemistry, Medicine +5
Effect of synthetic metalloprotease inhibitors on cartilage autolysis in vitro.
C.B. Caputo, Linda A. Sygowski, Donald J. Wolanin et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 31 citations
1–5 of 10